Hanmi acquires approval of combined treatment for ‘prostatic hypertrophy and erectile dysfunction’
On the 21st, Hanmi Pharm(CEO Gwan-Sun Lee) announced approval to commercialize ‘Gugutams Cap(generic name: tamsulosin 0.4mg+tadalafil 5mg)’ that combines substances for benign prostatic hypertrophy and erectile dysfunction from the Ministry of Food and Drug Safety.
As a ETC drug requiring docto...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
